<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">NAFTIFINE</span><br/>(naf'ti-feen)<br/><span class="topboxtradename">Naftin<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">antifungal</span><br/><b>Prototype: </b>Terbinafine<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1% cream, gel</p>
<h1><a name="action">Actions</a></h1>
<p>Synthetic broad-spectrum antifungal agent that may be fungicidal depending on the organism. Interferes in the synthesis of
         ergosterol, the principal sterol in the fungus cell membrane. Ergosterol becomes depleted and membrane function is affected.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Effective against topical infections caused by <i>Candida albicans, Epidermophyton floccosum, Microsporum canis, M. audouinii, M. gypseum, Trichophyton rubrum, T. mentagrophytes,</i> and <i>T. tonsurans</i>.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>
<i>Tinea pedis, tinea cruris,</i> and <i>tinea corporis</i>.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to naftifine.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Pregnancy (category B), lactation. Safety and efficacy in children are not established.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Tinea Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">Topical</span> Apply cream once daily, or apply gel twice daily, may use up to 4 wk<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Topical</span><br/><ul>
<li>Gently massage into affected area and surrounding skin. Wash hands before and after application.</li>
<li>Do not apply occlusive dressing unless specifically directed to do so.</li>
<li>Store at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Skin:</span> Burning or stinging, dryness, erythema, itching, local irritation. 
      <h1><a name="interactions">Interactions</a></h1>No clinically significant interactions established. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> 2.56% absorbed through intact skin. <span class="typehead">Onset:</span> 7 d. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine and feces. <span class="typehead">Half-Life:</span> 23 d. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Assess for irritation or sensitivity to cream; these are indications to discontinue use.</li>
<li>Reevaluate use of drug if no improvement is noted after 4 wk.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Learn correct application technique.</li>
<li>Avoid contact with eyes or mucous membranes.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>